Abstract:Objective. To review the clinical usefulness of N-acetylcysteine (NAC) as treatment or adjunctive therapy in a number of medical conditions. Use in Tylenol overdose, cystic fibrosis, and chronic obstructive lung disease has been well documented, but there is emerging evidence many other conditions would benefit from this safe, simple, and inexpensive intervention. Quality of Evidence. PubMed, several books, and conference proceedings were searched for articles on NAC and health conditions listed above reviewing supportive evidence. This study uses a traditional integrated review format, and clinically relevant information is assessed using the American Family Physician Evidence-Based Medicine Toolkit. A table summarizing the potential mechanisms of action for N-acetylcysteine in these conditions is presented. Main Message. N-acetylcysteine may be useful as an adjuvant in treating various medical conditions, especially chronic diseases. These conditions include polycystic ovary disease, male infertility, sleep apnea, acquired immune deficiency syndrome, influenza, parkinsonism, multiple sclerosis, peripheral neuropathy, stroke outcomes, diabetic neuropathy, Crohn’s disease, ulcerative colitis, schizophrenia, bipolar illness, and obsessive compulsive disorder; it can also be useful as a chelator for heavy metals and nanoparticles. There are also a number of other conditions that may show benefit; however, the evidence is not as robust. Conclusion. The use of N-acetylcysteine should be considered in a number of conditions as our population ages and levels of glutathione drop. Supplementation may contribute to reducing morbidity and mortality in some chronic conditions as outlined in the article.

Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases

The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress

N-acetylcysteine Clinical Applications

N-Acetylcysteine (NAC): Impacts on Human Health

N-acetylcysteine increases dopamine release and prevents the deleterious effects of 6-OHDA on the expression of VMAT2, α-synuclein, and tyrosine hydroxylase

N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant

N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks)

An insight on safety, efficacy, and molecular docking study reports of N-acetylcysteine and its compound formulations

N-acetylecysteine: The multiuse antioxidant

The Physiological Effects of N-Acetylcysteine in Clinical Studies

Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits

Superior Properties of N-Acetylcysteine Ethyl Ester over N-Acetyl Cysteine to Prevent Retinal Pigment Epithelial Cells Oxidative Damage

Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: Current Evidence and Potential use

The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

N-acetylcysteine (NAC) and Its Role in Clinical Practice Management of Cystic Fibrosis (CF): A Review

Advances in the Use of N-Acetylcysteine in Chronic Respiratory Diseases

Antioxidant and Neuroprotective Effects of Carnosine: Therapeutic Implications in Neurodegenerative Diseases

Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders

Protective Effect of N-acetyl-l-cysteine on Amyloid Β-Peptide-induced Learning and Memory Deficits in Mice

Neuroprotective Effects of Carnitine and Its Potential Application to Ameliorate Neurotoxicity

Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease